FDA Inspection 967541 — DOW LAO Blood Bank
The FDA completed an inspection of DOW LAO Blood Bank on April 7, 2016 in Plaquemine, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 7, 2016
- Fiscal Year
- 2016
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Plaquemine, LA (United States)